Applying GRADE to a network meta-analysis of antidepressants led to more conservative conclusions
To explore the impact of applying the Grading of Recommendations and Assessment, Development, and Evaluation (GRADE) approach to assess the certainty of the evidence in a published network meta-analysis (NMA) of antidepressant therapies. We applied the GRADE approach to rate the certainty of the evi...
Saved in:
Published in | Journal of Clinical Epidemiology Vol. 102; pp. 87 - 98 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.10.2018
Elsevier BV Elsevier Limited |
Subjects | |
Online Access | Get full text |
ISSN | 0895-4356 1878-5921 1878-5921 |
DOI | 10.1016/j.jclinepi.2018.05.009 |
Cover
Abstract | To explore the impact of applying the Grading of Recommendations and Assessment, Development, and Evaluation (GRADE) approach to assess the certainty of the evidence in a published network meta-analysis (NMA) of antidepressant therapies.
We applied the GRADE approach to rate the certainty of the evidence for two outcomes, efficacy and acceptability, in each of the 66 paired comparisons within a previously published NMA assessing the relative efficacy and acceptability of 12 new-generation antidepressants.
For the outcome of efficacy, of the 25 comparisons in which the 95% CrI of OR excluded 1, 18 had certainty of evidence rated high or moderate. For the outcome of acceptability, of the 13 comparisons whose 95% CrI excluded 1, 10 had certainty of evidence rated high or moderate. Of the 11 comparisons involving sertraline, the antidepressants that the authors of the NMA suggested to be best, only 3 demonstrated it to be more effective and only 3 showed better tolerance, based on a 95% CrI excluding 1 and a high or moderate rating of certainty.
In this example, application of GRADE highlighted varying evidence certainty, led to more conservative conclusions, and potentially avoided unwarranted strong inferences based on low certainty evidence. |
---|---|
AbstractList | To explore the impact of applying the Grading of Recommendations and Assessment, Development, and Evaluation (GRADE) approach to assess the certainty of the evidence in a published network meta-analysis (NMA) of antidepressant therapies.
We applied the GRADE approach to rate the certainty of the evidence for two outcomes, efficacy and acceptability, in each of the 66 paired comparisons within a previously published NMA assessing the relative efficacy and acceptability of 12 new-generation antidepressants.
For the outcome of efficacy, of the 25 comparisons in which the 95% CrI of OR excluded 1, 18 had certainty of evidence rated high or moderate. For the outcome of acceptability, of the 13 comparisons whose 95% CrI excluded 1, 10 had certainty of evidence rated high or moderate. Of the 11 comparisons involving sertraline, the antidepressants that the authors of the NMA suggested to be best, only 3 demonstrated it to be more effective and only 3 showed better tolerance, based on a 95% CrI excluding 1 and a high or moderate rating of certainty.
In this example, application of GRADE highlighted varying evidence certainty, led to more conservative conclusions, and potentially avoided unwarranted strong inferences based on low certainty evidence. To explore the impact of applying the Grading of Recommendations and Assessment, Development, and Evaluation (GRADE) approach to assess the certainty of the evidence in a published network meta-analysis (NMA) of antidepressant therapies.OBJECTIVETo explore the impact of applying the Grading of Recommendations and Assessment, Development, and Evaluation (GRADE) approach to assess the certainty of the evidence in a published network meta-analysis (NMA) of antidepressant therapies.We applied the GRADE approach to rate the certainty of the evidence for two outcomes, efficacy and acceptability, in each of the 66 paired comparisons within a previously published NMA assessing the relative efficacy and acceptability of 12 new-generation antidepressants.STUDY DESIGN AND SETTINGSWe applied the GRADE approach to rate the certainty of the evidence for two outcomes, efficacy and acceptability, in each of the 66 paired comparisons within a previously published NMA assessing the relative efficacy and acceptability of 12 new-generation antidepressants.For the outcome of efficacy, of the 25 comparisons in which the 95% CrI of OR excluded 1, 18 had certainty of evidence rated high or moderate. For the outcome of acceptability, of the 13 comparisons whose 95% CrI excluded 1, 10 had certainty of evidence rated high or moderate. Of the 11 comparisons involving sertraline, the antidepressants that the authors of the NMA suggested to be best, only 3 demonstrated it to be more effective and only 3 showed better tolerance, based on a 95% CrI excluding 1 and a high or moderate rating of certainty.RESULTSFor the outcome of efficacy, of the 25 comparisons in which the 95% CrI of OR excluded 1, 18 had certainty of evidence rated high or moderate. For the outcome of acceptability, of the 13 comparisons whose 95% CrI excluded 1, 10 had certainty of evidence rated high or moderate. Of the 11 comparisons involving sertraline, the antidepressants that the authors of the NMA suggested to be best, only 3 demonstrated it to be more effective and only 3 showed better tolerance, based on a 95% CrI excluding 1 and a high or moderate rating of certainty.In this example, application of GRADE highlighted varying evidence certainty, led to more conservative conclusions, and potentially avoided unwarranted strong inferences based on low certainty evidence.CONCLUSIONSIn this example, application of GRADE highlighted varying evidence certainty, led to more conservative conclusions, and potentially avoided unwarranted strong inferences based on low certainty evidence. ObjectiveTo explore the impact of applying the Grading of Recommendations and Assessment, Development, and Evaluation (GRADE) approach to assess the certainty of the evidence in a published network meta-analysis (NMA) of antidepressant therapies.Study design and settingsWe applied the GRADE approach to rate the certainty of the evidence for two outcomes, efficacy and acceptability, in each of the 66 paired comparisons within a previously published NMA assessing the relative efficacy and acceptability of 12 new-generation antidepressants.ResultsFor the outcome of efficacy, of the 25 comparisons in which the 95% CrI of OR excluded 1, 18 had certainty of evidence rated high or moderate. For the outcome of acceptability, of the 13 comparisons whose 95% CrI excluded 1, 10 had certainty of evidence rated high or moderate. Of the 11 comparisons involving sertraline, the antidepressants that the authors of the NMA suggested to be best, only 3 demonstrated it to be more effective and only 3 showed better tolerance, based on a 95% CrI excluding 1 and a high or moderate rating of certainty.ConclusionsIn this example, application of GRADE highlighted varying evidence certainty, led to more conservative conclusions, and potentially avoided unwarranted strong inferences based on low certainty evidence. |
Author | Alexander, Paul E. Agarwal, Arnav Wiercioch, Wojtek Yepes-Nuñez, Juan José Bonner, Ashley Siemieniuk, Reed A. Brignardello-Petersen, Romina Schünemann, Holger Florez, Ivan D. Guyatt, Gordon H. Zhang, Yuan Beyene, Joseph Furukawa, Toshi A. Fei, Yutong |
Author_xml | – sequence: 1 givenname: Ashley surname: Bonner fullname: Bonner, Ashley email: ashleybonner8@gmail.com organization: Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada – sequence: 2 givenname: Paul E. surname: Alexander fullname: Alexander, Paul E. organization: Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada – sequence: 3 givenname: Romina surname: Brignardello-Petersen fullname: Brignardello-Petersen, Romina organization: Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada – sequence: 4 givenname: Toshi A. surname: Furukawa fullname: Furukawa, Toshi A. organization: Departments of Health Promotion and Human Behavior and of Clinical Epidemiology, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan – sequence: 5 givenname: Reed A. surname: Siemieniuk fullname: Siemieniuk, Reed A. organization: Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada – sequence: 6 givenname: Yuan orcidid: 0000-0002-4174-0641 surname: Zhang fullname: Zhang, Yuan organization: Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada – sequence: 7 givenname: Wojtek orcidid: 0000-0001-6576-1650 surname: Wiercioch fullname: Wiercioch, Wojtek organization: Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada – sequence: 8 givenname: Ivan D. orcidid: 0000-0002-0751-8932 surname: Florez fullname: Florez, Ivan D. organization: Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada – sequence: 9 givenname: Yutong surname: Fei fullname: Fei, Yutong organization: Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada – sequence: 10 givenname: Arnav orcidid: 0000-0002-0931-7851 surname: Agarwal fullname: Agarwal, Arnav organization: Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada – sequence: 11 givenname: Juan José surname: Yepes-Nuñez fullname: Yepes-Nuñez, Juan José organization: Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada – sequence: 12 givenname: Joseph surname: Beyene fullname: Beyene, Joseph organization: Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada – sequence: 13 givenname: Holger surname: Schünemann fullname: Schünemann, Holger organization: Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada – sequence: 14 givenname: Gordon H. surname: Guyatt fullname: Guyatt, Gordon H. organization: Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada |
BackLink | https://cir.nii.ac.jp/crid/1873961342300676352$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/29800689$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkc1u1DAUhS1URKeFV6giwYJNgp3Ediwh1FEpBakSEoK15bFvkFOPHexk0Lw9TqezmU3Z-E_fuff6nAt05oMHhK4Irggm7MNQDdpZD6Otaky6CtMKY_ECrUjHu5KKmpyhFe4ELduGsnN0kdKAMeGY01fovBYdxqwTK6TW4-j21v8u7n6sP98WUyhU4WH6G-JDsYVJlcort082FaEvlJ-sgTFCSvmYCgdmUWxDhEIHnyDu1GR3jxft5mTz22v0slcuwZun_RL9-nL78-Zref_97tvN-r7UVLRTyTmtwZCaC9a3TLONYMYwzsimFu2mF6IzChQVtMEEtDBEGN50rdCccMBt3Vyi94e6Ywx_ZkiT3NqkwTnlIcxJ1rjNWk6wyOjbE3QIc8z_XChB2xo3tM3U1RM1b7Zg5BjtVsW9PJqXgY8HQMeQUoReajvl_wc_RWWdJFguWclBHrOSS1YSU4kfp2An8mOHZ4XvDkJvbW65rDn1RjDSZB_ybJw1dDHk-oBBdn1nIcqkLXgNxkbQkzTBPt_p00mJhbJauQfY_0-Bf-Vf0NM |
CitedBy_id | crossref_primary_10_1136_bmjopen_2022_065045 crossref_primary_10_1016_j_euf_2023_10_018 crossref_primary_10_1186_s12883_024_03649_5 crossref_primary_10_1136_bmjebm_2019_111191 crossref_primary_10_1007_s00784_021_04264_1 crossref_primary_10_1093_aje_kwae260 crossref_primary_10_1136_bmjopen_2023_075212 crossref_primary_10_1080_13548506_2023_2282958 crossref_primary_10_1177_00220345221130025 crossref_primary_10_1111_eos_13028 crossref_primary_10_3389_froh_2023_1110634 crossref_primary_10_1016_j_pnpbp_2022_110557 crossref_primary_10_1177_0022034520903036 crossref_primary_10_1007_s00784_020_03675_w crossref_primary_10_3389_fpubh_2022_1051581 |
Cites_doi | 10.1016/S0140-6736(09)60976-4 10.1017/S2045796016000020 10.1016/j.jclinepi.2010.03.016 10.1177/0272989X08323298 10.1016/S0140-6736(09)60975-2 10.1001/2012.jama.11228 10.1136/bmj.f3675 10.1016/j.jclinepi.2010.09.012 10.1002/sim.2934 10.1016/j.jclinepi.2010.07.015 10.1002/jrsm.12 10.1192/bjp.174.4.297 10.1016/S0140-6736(09)60977-6 10.1136/bmj.g5630 10.1186/s12916-016-0764-6 10.1016/S0140-6736(09)60978-8 10.1136/bmj.d5928 10.1016/j.jclinepi.2011.01.011 10.1176/appi.ajp.2015.15030331 10.1002/sim.3767 10.2165/00019053-200826090-00006 10.1016/S0895-4356(97)00049-8 10.1016/j.jclinepi.2010.04.026 10.1016/S0140-6736(09)60974-0 10.1016/j.jclinepi.2011.04.014 10.7326/0003-4819-155-11-201112060-00009 10.1016/S2215-0366(14)70314-1 10.1016/j.jclinepi.2010.07.017 10.1016/j.jclinepi.2010.09.011 10.1186/s13104-016-2019-1 10.1016/S0140-6736(09)60046-5 10.1177/0272989X12458724 10.1002/jrsm.1054 10.1016/S0140-6736(09)60973-9 10.1371/journal.pone.0086754 10.1002/jrsm.1167 10.1371/journal.pone.0099682 10.1016/j.jclinepi.2011.03.017 10.1136/bmj.39490.551019.BE |
ContentType | Journal Article |
Copyright | 2018 Elsevier Inc. Copyright © 2018 Elsevier Inc. All rights reserved. Copyright Elsevier Limited Oct 2018 |
Copyright_xml | – notice: 2018 Elsevier Inc. – notice: Copyright © 2018 Elsevier Inc. All rights reserved. – notice: Copyright Elsevier Limited Oct 2018 |
DBID | RYH AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7RV 7T2 7T7 7TK 7U7 7U9 7X7 7XB 88C 88E 8AO 8C1 8FD 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BENPR C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 K9. KB0 M0S M0T M1P M2O M7N MBDVC NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI Q9U 7X8 |
DOI | 10.1016/j.jclinepi.2018.05.009 |
DatabaseName | CiNii Complete CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Health and Safety Science Abstracts (Full archive) Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database (subscription) Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Healthcare Administration Database PML(ProQuest Medical Library) Research Library (subscription) Algology Mycology and Protozoology Abstracts (Microbiology C) Research Library (Corporate) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest Central Essentials Environmental Sciences and Pollution Management ProQuest One Sustainability Health Research Premium Collection Health & Medical Research Collection Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library Health & Safety Science Abstracts ProQuest Public Health ProQuest Central Basic Toxicology Abstracts ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Medical Library ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Research Library Prep |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1878-5921 |
EndPage | 98 |
ExternalDocumentID | 29800689 10_1016_j_jclinepi_2018_05_009 S0895435617310855 |
Genre | Journal Article |
GroupedDBID | --- --K --M -~X .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29K 4.4 457 4CK 4G. 53G 5GY 5RE 5VS 7-5 71M 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8G5 8P~ 9JM 9JO AABNK AAEDT AAEDW AAFJI AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAWTL AAXKI AAXUO AAYJJ AAYWO ABBQC ABFNM ABIVO ABJNI ABLJU ABMAC ABMMH ABMZM ABOCM ABUWG ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEUYN AEVXI AFFNX AFJKZ AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX AOMHK APXCP AQUVI ASPBG AVARZ AVWKF AXJTR AZFZN AZQEC BENPR BKEYQ BKOJK BLXMC BNPGV BPHCQ BVXVI CCPQU CS3 D-I DU5 DWQXO EBS EFJIC EFKBS EJD EMOBN EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HEH HMCUK HMK HMO HVGLF HZ~ IHE J1W KOM L7B M0T M1P M29 M2O M3W M41 MO0 N9A NAPCQ O-L O9- OAUVE OD~ OHT OO0 OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQQKQ PRBVW PROAC PSQYO PUEGO Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSB SSH SSO SSZ SV3 T5K UAP UKHRP WOW WUQ X7M XPP YHZ Z5R ZGI ~G- 3V. AACTN AAIAV ABLVK ABYKQ AFCTW AFKWA AHPSJ AJBFU AJOXV AKYCK AMFUW EFLBG F3I LCYCR RIG ZA5 AGRNS ALIPV RYH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7QP 7T2 7T7 7TK 7U7 7U9 7XB 8FD 8FK C1K FR3 H94 K9. M7N MBDVC P64 PKEHL PQEST PQUKI Q9U 7X8 |
ID | FETCH-LOGICAL-c594t-7752ed12796f46c6b96dd6761b294bf998daea595301ec9d19d73849c717e0423 |
IEDL.DBID | 8C1 |
ISSN | 0895-4356 1878-5921 |
IngestDate | Fri Sep 05 13:12:34 EDT 2025 Wed Aug 13 10:59:54 EDT 2025 Thu Apr 03 07:08:30 EDT 2025 Tue Jul 01 03:10:45 EDT 2025 Thu Apr 24 23:03:13 EDT 2025 Fri Jun 27 00:29:51 EDT 2025 Fri Feb 23 02:32:18 EST 2024 Tue Aug 26 17:23:29 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | GRADE approach Network meta-analysis Results interpretation Certainty of the evidence |
Language | English |
License | Copyright © 2018 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c594t-7752ed12796f46c6b96dd6761b294bf998daea595301ec9d19d73849c717e0423 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-0751-8932 0000-0001-6576-1650 0000-0002-4174-0641 0000-0002-0931-7851 0000-0003-2159-3776 0000-0002-9912-0031 0000-0003-3211-8479 |
OpenAccessLink | https://cir.nii.ac.jp/crid/1873961342300676352 |
PMID | 29800689 |
PQID | 2095420354 |
PQPubID | 105585 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_2045307109 proquest_journals_2095420354 pubmed_primary_29800689 crossref_citationtrail_10_1016_j_jclinepi_2018_05_009 crossref_primary_10_1016_j_jclinepi_2018_05_009 nii_cinii_1873961342300676352 elsevier_sciencedirect_doi_10_1016_j_jclinepi_2018_05_009 elsevier_clinicalkey_doi_10_1016_j_jclinepi_2018_05_009 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | October 2018 2018-10-01 2018-10-00 20181001 |
PublicationDateYYYYMMDD | 2018-10-01 |
PublicationDate_xml | – month: 10 year: 2018 text: October 2018 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Elmsford |
PublicationTitle | Journal of Clinical Epidemiology |
PublicationTitleAlternate | J Clin Epidemiol |
PublicationYear | 2018 |
Publisher | Elsevier Inc Elsevier BV Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier BV – name: Elsevier Limited |
References | van Vallkenhoef, Lu, de Brock, Hillege, Ades, Welton (bib33) 2012; 3 Furukawa, Miura, Chaimani, Leucht, Cipriani, Noma (bib49) 2016; 9 Gartlehner, Gaynes, Hansen, Lohr (bib18) 2009; 373 Schwan, Hallberg (bib21) 2009; 373 Glenny, Altman, Song, Sakarovitch, Deeks, D’Amico (bib5) 2005; 9 Salanti, Del Giovane, Chaimani, Caldwell, Higgins (bib26) 2014; 9 Salanti, Ades, Ioannidis (bib44) 2011; 64 Borenstein, Hedges, Higgins, Rothstein (bib2) 2010; 1 Dias, Sutton, Ades, Welton (bib30) 2013; 33 R: A language and environment for statistical computing 2016. Bollini, Pampallona, Tibaldi, Kupelnick, Munizza (bib47) 1999; 174 Hansen, Moore, Dusetzina, Leinwand, Gartlehner, Gaynes (bib29) 2009; 29 Ioannidis (bib19) 2009; 373 Kessler, van Loo, Wardenaar, Bossarte, Brenner, Ebert (bib46) 2017; 26 Brignardello-Petersen, Bonner, Alexander, Siemieniuk, Furukawa, Rochwerg (bib16) 2017 Gartlehner, Hansen, Morgan, Thaler, Lux, Van Noord (bib27) 2011; 155 Bafeta, Trinquart, Seror, Ravaud (bib8) 2013; 347 Guyatt, Oxman, Kunz, Atkins, Brozek, Vist (bib36) 2011; 64 Guyatt, Oxman, Montori, Vist, Kunz, Brozek (bib40) 2011; 64 Puhan, Schunemann, Murad, Li, Brignardello-Petersen, Singh (bib15) 2014; 349 Sutton, Ades, Cooper, Abrams (bib6) 2008; 26 Cipriani, Furukawa, Salanti, Geddes, Higgins, Churchill (bib17) 2009; 373 Miura, Noma, Furukawa, Mitsuyasu, Tanaka, Stockton (bib10) 2014; 1 Jakubovski, Varigonda, Freemantle, Taylor, Bloch (bib48) 2016; 173 Guyatt, Oxman, Kunz, Vist, Falck-Ytter, Schunemann (bib13) 2008; 336 Sutton, Higgins (bib4) 2008; 27 Turner, Moreno, Sutton (bib23) 2009; 373 Borenstein, Hedges, Higgins, Rothstein (bib3) 2009 Higgins JP, Lasserson T, Chandler J, Tovey D, R C. Methodologcal expectations of cochrane interventions reviews 2016. Mills, Ioannidis, Thorlund, Schünemann, Puhan, Guyatt (bib9) 2012; 308 Jefferson (bib20) 2009; 373 Guyatt, Oxman, Schunemann, Tugwell, Knottnerus (bib14) 2011; 64 Guyatt, Oxman, Kunz, Woodcock, Brozek, Helfand (bib39) 2011; 64 Nikolakopoulou, Chaimani, Veroniki, Vasiliadis, Schmid, Salanti (bib7) 2014; 9 Guyatt, Oxman, Vist, Kunz, Brozek, Alonso-Coello (bib37) 2011; 64 Guyatt, Oxman, Kunz, Woodcock, Brozek, Helfand (bib38) 2011; 64 Dias, Welton, Caldwell, Ades (bib31) 2010; 29 (bib25) 2011 Guyatt G, Rennie D, Meade MO, Cook DJ. Users’ guides to the medical literature: a manual for evidence-based clinical practice 2015. Seyringer, Kasper (bib22) 2009; 373 Bucher, Guyatt, Griffith, Walter (bib42) 1997; 50 Higgins, Altman, Gøtzsche, Jüni, Moher, Oxman (bib24) 2011; 343 Gartlehner, Hansen, Thieda, DeVeaugh-Geiss, Gaynes, Krebs (bib28) 2007 Zarin, Veroniki, Nincic, Vafaei, Reynen, Motiwala (bib11) 2017; 15 GH G, JW B. Modification of Cochrane Tool to assess risk of bias in randomized trials 2016. Balshem, Helfand, Schunemann, Oxman, Kunz, Brozek (bib35) 2011; 64 Dias, Welton, Caldwell, Ades (bib43) 2010; 29 van Valkenhoef, Dias, Ades, Welton (bib32) 2016; 7 Guyatt, Oxman, Akl, Kunz, Vist, Brozek (bib12) 2011; 64 Gartlehner (10.1016/j.jclinepi.2018.05.009_bib27) 2011; 155 Miura (10.1016/j.jclinepi.2018.05.009_bib10) 2014; 1 Furukawa (10.1016/j.jclinepi.2018.05.009_bib49) 2016; 9 (10.1016/j.jclinepi.2018.05.009_bib25) 2011 10.1016/j.jclinepi.2018.05.009_bib34 Salanti (10.1016/j.jclinepi.2018.05.009_bib44) 2011; 64 Puhan (10.1016/j.jclinepi.2018.05.009_bib15) 2014; 349 Brignardello-Petersen (10.1016/j.jclinepi.2018.05.009_bib16) 2017 Hansen (10.1016/j.jclinepi.2018.05.009_bib29) 2009; 29 Guyatt (10.1016/j.jclinepi.2018.05.009_bib36) 2011; 64 Dias (10.1016/j.jclinepi.2018.05.009_bib30) 2013; 33 Cipriani (10.1016/j.jclinepi.2018.05.009_bib17) 2009; 373 Higgins (10.1016/j.jclinepi.2018.05.009_bib24) 2011; 343 Guyatt (10.1016/j.jclinepi.2018.05.009_bib14) 2011; 64 Sutton (10.1016/j.jclinepi.2018.05.009_bib4) 2008; 27 Kessler (10.1016/j.jclinepi.2018.05.009_bib46) 2017; 26 Mills (10.1016/j.jclinepi.2018.05.009_bib9) 2012; 308 Guyatt (10.1016/j.jclinepi.2018.05.009_bib37) 2011; 64 Gartlehner (10.1016/j.jclinepi.2018.05.009_bib28) 2007 Borenstein (10.1016/j.jclinepi.2018.05.009_bib3) 2009 Guyatt (10.1016/j.jclinepi.2018.05.009_bib40) 2011; 64 Dias (10.1016/j.jclinepi.2018.05.009_bib31) 2010; 29 van Valkenhoef (10.1016/j.jclinepi.2018.05.009_bib32) 2016; 7 Nikolakopoulou (10.1016/j.jclinepi.2018.05.009_bib7) 2014; 9 Glenny (10.1016/j.jclinepi.2018.05.009_bib5) 2005; 9 Ioannidis (10.1016/j.jclinepi.2018.05.009_bib19) 2009; 373 Jakubovski (10.1016/j.jclinepi.2018.05.009_bib48) 2016; 173 Guyatt (10.1016/j.jclinepi.2018.05.009_bib38) 2011; 64 Bucher (10.1016/j.jclinepi.2018.05.009_bib42) 1997; 50 Dias (10.1016/j.jclinepi.2018.05.009_bib43) 2010; 29 Bafeta (10.1016/j.jclinepi.2018.05.009_bib8) 2013; 347 Jefferson (10.1016/j.jclinepi.2018.05.009_bib20) 2009; 373 Guyatt (10.1016/j.jclinepi.2018.05.009_bib12) 2011; 64 Borenstein (10.1016/j.jclinepi.2018.05.009_bib2) 2010; 1 Gartlehner (10.1016/j.jclinepi.2018.05.009_bib18) 2009; 373 Salanti (10.1016/j.jclinepi.2018.05.009_bib26) 2014; 9 10.1016/j.jclinepi.2018.05.009_bib41 Zarin (10.1016/j.jclinepi.2018.05.009_bib11) 2017; 15 Seyringer (10.1016/j.jclinepi.2018.05.009_bib22) 2009; 373 10.1016/j.jclinepi.2018.05.009_bib45 Balshem (10.1016/j.jclinepi.2018.05.009_bib35) 2011; 64 van Vallkenhoef (10.1016/j.jclinepi.2018.05.009_bib33) 2012; 3 10.1016/j.jclinepi.2018.05.009_bib1 Guyatt (10.1016/j.jclinepi.2018.05.009_bib13) 2008; 336 Turner (10.1016/j.jclinepi.2018.05.009_bib23) 2009; 373 Guyatt (10.1016/j.jclinepi.2018.05.009_bib39) 2011; 64 Schwan (10.1016/j.jclinepi.2018.05.009_bib21) 2009; 373 Bollini (10.1016/j.jclinepi.2018.05.009_bib47) 1999; 174 Sutton (10.1016/j.jclinepi.2018.05.009_bib6) 2008; 26 |
References_xml | – volume: 7 start-page: 80 year: 2016 end-page: 93 ident: bib32 article-title: Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis publication-title: Res Synth Methods – volume: 50 start-page: 683 year: 1997 end-page: 691 ident: bib42 article-title: The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials publication-title: J Clin Epidemiol – volume: 349 start-page: g5630 year: 2014 ident: bib15 article-title: A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis publication-title: BMJ – volume: 173 start-page: 174 year: 2016 end-page: 183 ident: bib48 article-title: Systematic review and meta-analysis: dose-response relationship of selective serotonin reuptake inhibitors in major depressive disorder publication-title: Am J Psychiatry – volume: 29 start-page: 932 year: 2010 end-page: 944 ident: bib31 article-title: Checking consistency in mixed treatment comparison meta-analysis publication-title: Stat Med – volume: 64 start-page: 1277 year: 2011 end-page: 1282 ident: bib40 article-title: GRADE guidelines: 5. Rating the quality of evidence–publication bias publication-title: J Clin Epidemiol – volume: 64 start-page: 401 year: 2011 end-page: 406 ident: bib35 article-title: GRADE guidelines: 3. Rating the quality of evidence publication-title: J Clin Epidemiol – volume: 64 start-page: 1303 year: 2011 end-page: 1310 ident: bib39 article-title: GRADE guidelines: 8. Rating the quality of evidence–indirectness publication-title: J Clin Epidemiol – volume: 9 start-page: e86754 year: 2014 ident: bib7 article-title: Characteristics of networks of interventions: a description of a database of 186 published networks publication-title: PLoS One – reference: Guyatt G, Rennie D, Meade MO, Cook DJ. Users’ guides to the medical literature: a manual for evidence-based clinical practice 2015. – volume: 9 year: 2005 ident: bib5 article-title: Indirect comparisons of competing interventions publication-title: Heal Technol Assess – year: 2007 ident: bib28 article-title: AHRQ Comparative Effectiveness Reviews. Comp. Eff. Second. Antidepressants Pharmacol. Treat. Adult Depress – volume: 155 start-page: 772 year: 2011 end-page: 785 ident: bib27 article-title: Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis publication-title: Ann Intern Med – volume: 347 start-page: f3675 year: 2013 ident: bib8 article-title: Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review publication-title: BMJ – volume: 373 start-page: 1761 year: 2009 ident: bib18 article-title: Ranking antidepressants publication-title: Lancet – volume: 29 start-page: 932 year: 2010 end-page: 944 ident: bib43 article-title: Checking consistency in mixed treatment comparison meta-analysis publication-title: Stat Med – volume: 373 start-page: 746 year: 2009 end-page: 758 ident: bib17 article-title: Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis publication-title: Lancet – reference: R: A language and environment for statistical computing 2016. – volume: 26 start-page: 753 year: 2008 end-page: 767 ident: bib6 article-title: Use of indirect and mixed treatment comparisons for technology assessment publication-title: Pharmacoeconomics – year: 2017 ident: bib16 article-title: Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis publication-title: J Clin Epidemiol – volume: 373 start-page: 1761 year: 2009 ident: bib21 article-title: Ranking antidepressants publication-title: Lancet – volume: 308 start-page: 1246 year: 2012 end-page: 1253 ident: bib9 article-title: How to use an article reporting a multiple treatment comparison meta-analysis multiple treatment comparison meta-analysis publication-title: JAMA – volume: 1 start-page: 97 year: 2010 end-page: 111 ident: bib2 article-title: A basic introduction to fixed-effect and random-effects models for meta-analysis publication-title: Res Synth Methods – volume: 336 start-page: 995 year: 2008 end-page: 998 ident: bib13 article-title: What is “quality of evidence” and why is it important to clinicians? publication-title: BMJ – volume: 64 start-page: 163 year: 2011 end-page: 171 ident: bib44 article-title: Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial publication-title: J Clin Epidemiol – volume: 373 start-page: 1760 year: 2009 end-page: 1762 ident: bib22 article-title: Ranking antidepressants publication-title: Lancet – volume: 373 start-page: 1760 year: 2009 ident: bib23 article-title: Ranking antidepressants publication-title: Lancet – volume: 64 start-page: 380 year: 2011 end-page: 382 ident: bib14 article-title: GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology publication-title: J Clin Epidemiol – volume: 64 start-page: 395 year: 2011 end-page: 400 ident: bib36 article-title: GRADE guidelines: 2. Framing the question and deciding on important outcomes publication-title: J Clin Epidemiol – volume: 33 start-page: 607 year: 2013 end-page: 617 ident: bib30 article-title: Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials publication-title: Med Decis Mak – volume: 1 start-page: 351 year: 2014 end-page: 359 ident: bib10 article-title: Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis publication-title: Lancet Psychiatry – volume: 343 start-page: d5928 year: 2011 ident: bib24 article-title: The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials publication-title: BMJ – volume: 64 start-page: 1294 year: 2011 end-page: 1302 ident: bib38 article-title: GRADE guidelines: 7. Rating the quality of evidence–inconsistency publication-title: J Clin Epidemiol – volume: 9 year: 2014 ident: bib26 article-title: Evaluating the quality of evidence from a network meta-analysis publication-title: PLoS One – volume: 27 start-page: 625 year: 2008 end-page: 650 ident: bib4 article-title: Recent developments in meta-analysis publication-title: Stat Med – year: 2009 ident: bib3 article-title: Introduction to meta-analysis – volume: 174 start-page: 297 year: 1999 end-page: 303 ident: bib47 article-title: Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials publication-title: Br J Psychiatry – volume: 373 start-page: 1759 year: 2009 ident: bib20 article-title: Ranking antidepressants publication-title: Lancet – volume: 29 start-page: 91 year: 2009 end-page: 103 ident: bib29 article-title: Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose publication-title: Med Decis Mak – volume: 64 start-page: 383 year: 2011 end-page: 394 ident: bib12 article-title: GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables publication-title: J Clin Epidemiol – volume: 373 start-page: 1752 year: 2009 end-page: 1759 ident: bib19 article-title: Ranking antidepressants publication-title: Lancet – volume: 15 start-page: 3 year: 2017 ident: bib11 article-title: Characteristics and knowledge synthesis approach for 456 network meta-analyses: a scoping review publication-title: BMC Med – volume: 3 start-page: 285 year: 2012 end-page: 299 ident: bib33 article-title: Automating network meta-analysis publication-title: Res Synth Methods – reference: GH G, JW B. Modification of Cochrane Tool to assess risk of bias in randomized trials 2016. – reference: Higgins JP, Lasserson T, Chandler J, Tovey D, R C. Methodologcal expectations of cochrane interventions reviews 2016. – year: 2011 ident: bib25 article-title: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] – volume: 26 start-page: 22 year: 2017 end-page: 36 ident: bib46 article-title: Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder publication-title: Epidemiol Psychiatr Sci – volume: 9 start-page: 218 year: 2016 ident: bib49 article-title: Using the contribution matrix to evaluate complex study limitations in a network meta-analysis: a case study of bipolar maintenance pharmacotherapy review publication-title: BMC Res Notes – volume: 64 start-page: 407 year: 2011 end-page: 415 ident: bib37 article-title: GRADE guidelines: 4. Rating the quality of evidence–study limitations (risk of bias) publication-title: J Clin Epidemiol – volume: 373 start-page: 1760 year: 2009 ident: 10.1016/j.jclinepi.2018.05.009_bib22 article-title: Ranking antidepressants publication-title: Lancet doi: 10.1016/S0140-6736(09)60976-4 – volume: 26 start-page: 22 year: 2017 ident: 10.1016/j.jclinepi.2018.05.009_bib46 article-title: Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder publication-title: Epidemiol Psychiatr Sci doi: 10.1017/S2045796016000020 – volume: 64 start-page: 163 year: 2011 ident: 10.1016/j.jclinepi.2018.05.009_bib44 article-title: Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2010.03.016 – volume: 29 start-page: 91 year: 2009 ident: 10.1016/j.jclinepi.2018.05.009_bib29 article-title: Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose publication-title: Med Decis Mak doi: 10.1177/0272989X08323298 – year: 2017 ident: 10.1016/j.jclinepi.2018.05.009_bib16 article-title: Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis publication-title: J Clin Epidemiol – volume: 373 start-page: 1760 year: 2009 ident: 10.1016/j.jclinepi.2018.05.009_bib23 article-title: Ranking antidepressants publication-title: Lancet doi: 10.1016/S0140-6736(09)60975-2 – volume: 308 start-page: 1246 year: 2012 ident: 10.1016/j.jclinepi.2018.05.009_bib9 article-title: How to use an article reporting a multiple treatment comparison meta-analysis multiple treatment comparison meta-analysis publication-title: JAMA doi: 10.1001/2012.jama.11228 – ident: 10.1016/j.jclinepi.2018.05.009_bib41 – volume: 347 start-page: f3675 year: 2013 ident: 10.1016/j.jclinepi.2018.05.009_bib8 article-title: Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review publication-title: BMJ doi: 10.1136/bmj.f3675 – ident: 10.1016/j.jclinepi.2018.05.009_bib34 – volume: 64 start-page: 395 year: 2011 ident: 10.1016/j.jclinepi.2018.05.009_bib36 article-title: GRADE guidelines: 2. Framing the question and deciding on important outcomes publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2010.09.012 – volume: 27 start-page: 625 year: 2008 ident: 10.1016/j.jclinepi.2018.05.009_bib4 article-title: Recent developments in meta-analysis publication-title: Stat Med doi: 10.1002/sim.2934 – volume: 64 start-page: 401 year: 2011 ident: 10.1016/j.jclinepi.2018.05.009_bib35 article-title: GRADE guidelines: 3. Rating the quality of evidence publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2010.07.015 – volume: 1 start-page: 97 year: 2010 ident: 10.1016/j.jclinepi.2018.05.009_bib2 article-title: A basic introduction to fixed-effect and random-effects models for meta-analysis publication-title: Res Synth Methods doi: 10.1002/jrsm.12 – year: 2007 ident: 10.1016/j.jclinepi.2018.05.009_bib28 – volume: 174 start-page: 297 year: 1999 ident: 10.1016/j.jclinepi.2018.05.009_bib47 article-title: Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials publication-title: Br J Psychiatry doi: 10.1192/bjp.174.4.297 – ident: 10.1016/j.jclinepi.2018.05.009_bib1 – ident: 10.1016/j.jclinepi.2018.05.009_bib45 – volume: 373 start-page: 1761 year: 2009 ident: 10.1016/j.jclinepi.2018.05.009_bib21 article-title: Ranking antidepressants publication-title: Lancet doi: 10.1016/S0140-6736(09)60977-6 – volume: 349 start-page: g5630 year: 2014 ident: 10.1016/j.jclinepi.2018.05.009_bib15 article-title: A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis publication-title: BMJ doi: 10.1136/bmj.g5630 – volume: 15 start-page: 3 year: 2017 ident: 10.1016/j.jclinepi.2018.05.009_bib11 article-title: Characteristics and knowledge synthesis approach for 456 network meta-analyses: a scoping review publication-title: BMC Med doi: 10.1186/s12916-016-0764-6 – volume: 373 start-page: 1761 year: 2009 ident: 10.1016/j.jclinepi.2018.05.009_bib18 article-title: Ranking antidepressants publication-title: Lancet doi: 10.1016/S0140-6736(09)60978-8 – volume: 343 start-page: d5928 year: 2011 ident: 10.1016/j.jclinepi.2018.05.009_bib24 article-title: The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials publication-title: BMJ doi: 10.1136/bmj.d5928 – year: 2009 ident: 10.1016/j.jclinepi.2018.05.009_bib3 – volume: 64 start-page: 1277 year: 2011 ident: 10.1016/j.jclinepi.2018.05.009_bib40 article-title: GRADE guidelines: 5. Rating the quality of evidence–publication bias publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2011.01.011 – volume: 173 start-page: 174 year: 2016 ident: 10.1016/j.jclinepi.2018.05.009_bib48 article-title: Systematic review and meta-analysis: dose-response relationship of selective serotonin reuptake inhibitors in major depressive disorder publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2015.15030331 – volume: 29 start-page: 932 year: 2010 ident: 10.1016/j.jclinepi.2018.05.009_bib31 article-title: Checking consistency in mixed treatment comparison meta-analysis publication-title: Stat Med doi: 10.1002/sim.3767 – year: 2011 ident: 10.1016/j.jclinepi.2018.05.009_bib25 – volume: 26 start-page: 753 year: 2008 ident: 10.1016/j.jclinepi.2018.05.009_bib6 article-title: Use of indirect and mixed treatment comparisons for technology assessment publication-title: Pharmacoeconomics doi: 10.2165/00019053-200826090-00006 – volume: 50 start-page: 683 year: 1997 ident: 10.1016/j.jclinepi.2018.05.009_bib42 article-title: The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials publication-title: J Clin Epidemiol doi: 10.1016/S0895-4356(97)00049-8 – volume: 64 start-page: 383 year: 2011 ident: 10.1016/j.jclinepi.2018.05.009_bib12 article-title: GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2010.04.026 – volume: 373 start-page: 1752 year: 2009 ident: 10.1016/j.jclinepi.2018.05.009_bib19 article-title: Ranking antidepressants publication-title: Lancet doi: 10.1016/S0140-6736(09)60974-0 – volume: 9 year: 2005 ident: 10.1016/j.jclinepi.2018.05.009_bib5 article-title: Indirect comparisons of competing interventions publication-title: Heal Technol Assess – volume: 64 start-page: 1303 year: 2011 ident: 10.1016/j.jclinepi.2018.05.009_bib39 article-title: GRADE guidelines: 8. Rating the quality of evidence–indirectness publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2011.04.014 – volume: 155 start-page: 772 year: 2011 ident: 10.1016/j.jclinepi.2018.05.009_bib27 article-title: Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis publication-title: Ann Intern Med doi: 10.7326/0003-4819-155-11-201112060-00009 – volume: 1 start-page: 351 year: 2014 ident: 10.1016/j.jclinepi.2018.05.009_bib10 article-title: Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(14)70314-1 – volume: 64 start-page: 407 year: 2011 ident: 10.1016/j.jclinepi.2018.05.009_bib37 article-title: GRADE guidelines: 4. Rating the quality of evidence–study limitations (risk of bias) publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2010.07.017 – volume: 64 start-page: 380 year: 2011 ident: 10.1016/j.jclinepi.2018.05.009_bib14 article-title: GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2010.09.011 – volume: 9 start-page: 218 year: 2016 ident: 10.1016/j.jclinepi.2018.05.009_bib49 article-title: Using the contribution matrix to evaluate complex study limitations in a network meta-analysis: a case study of bipolar maintenance pharmacotherapy review publication-title: BMC Res Notes doi: 10.1186/s13104-016-2019-1 – volume: 373 start-page: 746 year: 2009 ident: 10.1016/j.jclinepi.2018.05.009_bib17 article-title: Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis publication-title: Lancet doi: 10.1016/S0140-6736(09)60046-5 – volume: 33 start-page: 607 year: 2013 ident: 10.1016/j.jclinepi.2018.05.009_bib30 article-title: Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials publication-title: Med Decis Mak doi: 10.1177/0272989X12458724 – volume: 3 start-page: 285 year: 2012 ident: 10.1016/j.jclinepi.2018.05.009_bib33 article-title: Automating network meta-analysis publication-title: Res Synth Methods doi: 10.1002/jrsm.1054 – volume: 373 start-page: 1759 year: 2009 ident: 10.1016/j.jclinepi.2018.05.009_bib20 article-title: Ranking antidepressants publication-title: Lancet doi: 10.1016/S0140-6736(09)60973-9 – volume: 9 start-page: e86754 year: 2014 ident: 10.1016/j.jclinepi.2018.05.009_bib7 article-title: Characteristics of networks of interventions: a description of a database of 186 published networks publication-title: PLoS One doi: 10.1371/journal.pone.0086754 – volume: 7 start-page: 80 year: 2016 ident: 10.1016/j.jclinepi.2018.05.009_bib32 article-title: Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis publication-title: Res Synth Methods doi: 10.1002/jrsm.1167 – volume: 9 year: 2014 ident: 10.1016/j.jclinepi.2018.05.009_bib26 article-title: Evaluating the quality of evidence from a network meta-analysis publication-title: PLoS One doi: 10.1371/journal.pone.0099682 – volume: 64 start-page: 1294 year: 2011 ident: 10.1016/j.jclinepi.2018.05.009_bib38 article-title: GRADE guidelines: 7. Rating the quality of evidence–inconsistency publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2011.03.017 – volume: 336 start-page: 995 year: 2008 ident: 10.1016/j.jclinepi.2018.05.009_bib13 article-title: What is “quality of evidence” and why is it important to clinicians? publication-title: BMJ doi: 10.1136/bmj.39490.551019.BE – volume: 29 start-page: 932 year: 2010 ident: 10.1016/j.jclinepi.2018.05.009_bib43 article-title: Checking consistency in mixed treatment comparison meta-analysis publication-title: Stat Med doi: 10.1002/sim.3767 |
SSID | ssj0017075 ssib000829727 ssib006545733 |
Score | 2.359573 |
Snippet | To explore the impact of applying the Grading of Recommendations and Assessment, Development, and Evaluation (GRADE) approach to assess the certainty of the... ObjectiveTo explore the impact of applying the Grading of Recommendations and Assessment, Development, and Evaluation (GRADE) approach to assess the certainty... |
SourceID | proquest pubmed crossref nii elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 87 |
SubjectTerms | Acceptability Antidepressants Antidepressive Agents Antidepressive Agents - therapeutic use Certainty of the evidence Depressive Disorder Depressive Disorder - drug therapy Effectiveness Epidemiology Estimates Evaluation Evidence-Based Medicine GRADE Approach GRADE Approach - methods Humans Meta-analysis Network Meta-Analysis Network Meta-Analysis As Topic Patients Quality Results interpretation Sertraline Systematic review Treatment Outcome |
SummonAdditionalLinks | – databaseName: ScienceDirect Freedom Collection Journals dbid: AIKHN link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da5xAEB-SC5S-lKaftknYQl_tee6HzmMITa4pyUPbQN5Ed1fwuHhH4_Xv74yu0kJLCn0RVh3Qn_O17m9mAd7LWjqUiYsdYhmrKrUxkiOMpdGYyErlznDt8NW1Wd6oy1t9uwdnYy0M0yqD7x98eu-tw5l5QHO-bZr51yRHTcGeQrBkCr3eh4OUon0-g4PTT5-X19NiQjb02-X7Yxb4pVB49WHFFYh-2zDLK--beDI38c8xar9tmr9non1EOn8KT0IqKU6Hpz2EPd8-g0dXYbH8OZScYXIVk7j4QniLbiNK0Q60b3HnuzIuQ0cSsakFIdwEWixTY8TaO5ZgHq6wTLnuf97-6Ad2veOfbPcv4Ob847ezZRx2VIitRtVRKq1T7xZphqZWxpoKjXMmM4sqRVXVNPVypS81ajJ7b9Et0GUyV2hp0ueZQfMSZu2m9a9BlC5LyaBriwkFOG-rjGZGLkFHNl27KolAjxgWNrQb510v1sXIK1sVI_YFY18kuiDsI5hPctuh4caDEtn4iYqxnJQcYEEx4UFJnCR_U7p_kj0mbaBX4-MizyRSYkQIcfinJC6N4GjUkyK4hXuSJ5VNE6lVBO-my2TQvEpTtn6z43sUwc8U2QheDfo1AZGSHSUmxzf_8eBv4TGPBkLiEcy67zt_TIlVV50Ew_kJwnUdxQ priority: 102 providerName: Elsevier |
Title | Applying GRADE to a network meta-analysis of antidepressants led to more conservative conclusions |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0895435617310855 https://dx.doi.org/10.1016/j.jclinepi.2018.05.009 https://cir.nii.ac.jp/crid/1873961342300676352 https://www.ncbi.nlm.nih.gov/pubmed/29800689 https://www.proquest.com/docview/2095420354 https://www.proquest.com/docview/2045307109 |
Volume | 102 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9NAEF6RVkJcEG8MbbRIXF382IfnhErVEkCNUEWl3Fb27lpKlNqBJBz57czYa8MBKBdHkTORPbsz883uN7OMvc7r3EGeuNgBlLGoMhsDOsI4VxKSvBKFU1Q7fDlXs2vxcSEXYcFtG2iVg0_sHLVrLa2RY5IOUmRJLsXbzdeYTo2i3dVwhMaEHVINKCVfxdlI8Uh132g3KUDGCAvUbxXCq5MVlR76zZLoXUXXvZNIiX8OTpNmufw7BO1C0cUDdj9gSH7aD_pDdsc3j9jdy7BL_piVBC2pfIm_v0JF813LS970fG9-43dlXIZWJLytOap2GfiwxInha-9Iggi43BLXulu1_d59ses9ra5tn7Dri_MvZ7M4HKUQWwlihxhaZt6lmQZVC2VVBco5pVVaZSCqGnMuV_pSgkR79xZcCk7nhQCL2Z4n6sxTdtC0jX_OeOl0hpZcW0gwsnlbaUyJXAIOjbl2VRIxOejQ2NBnnI67WJuBULYyg-4N6d4k0qDuI_ZmlNv0nTZuldDDEJmhjhQ9n8FgcKskjJIBafQI4r9kj3E24KvRNS10DoiIUEMU9xG9ZRE7GuaJCf5ga37N3oi9Gm-jJdP2TNn4dk-_Eah-4sZG7Fk_v0ZFZGhAiSrgxb___CW7R0_akw2P2MHu294fI2jaVVM2OfmR4lUv9LSzkik7PP3waTbHz3fn889XPwHWHxai |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB61Wwm4IN4EWjASHANZx07iQ4V4tGxpd4WqVurNOLYj7WqbbNksiD_Hb2Mmj4UDUC69rBRtJkrGnvE39jczAM_jInYqjlzolDKhyLkNFTrCME6kiuJcZC6h3OHxJBmdio9n8mwDfvS5MESr7H1i46hdZWmPHIN0JQWPYileLy5C6hpFp6t9Cw3TtVZwu02JsS6x49B__4Yh3HL34D2O9wvO9_dO3o3CrstAaKUSNcJLyb0b8lQlhUhskqvEuQSj-5wrkRcYjjjjjVQSTcFb5YbKpXEmlMVAyBOrBJ-7CVuCNlAGsPV2b_LpeH2OkbalfqNMyRDvSH7LUZ69nFHyo19MiWCWNfVDiRb55-Vxs5xO_w6Cm8Vw_xbc7FAse9NOu9uw4cs7cG3cndPfBUPglhKo2IdjHGpWV8ywsmWcs3Nfm9B0xVBYVTBDKm0ZucTKYXPvSIIowMwS27vZN_7aXNj5ivb3lvfg9ErUfB8GZVX6h8CMSzn6ksKqCNdWb_MUgzIXKYfupHB5FIDsdahtV-mcGm7MdU9pm-le95p0ryOpUfcBvFrLLdpaH5dKpP0Q6T6TFX2vxuXoUkm1luywToth_kt2B2cDfhr9DrM0VojJUEOEPBA_8gC2-3miO4-01L_sJ4Bn67_Rl9ABkSl9taJ7BKqf2LkBPGjn11oRHE04SjL16N8PfwrXRyfjI310MDl8DDforVvq4zYM6i8rv4MQrs6fdHbC4PNVm-ZPNBlT6g |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELf2IU28IL4X2MBI8BiWOrYTP0wI2MrGWDVNTNqbcWxHalWSQlMQ_yJ_FXeJE3gAxsteKlXtRe35Pn5n_-5MyLO0TJ1KExc7pUzMC2ZjBYEwTqVQSVrw3EnsHT6dyKML_u5SXK6RH30vDNIq-5jYBmpXW9wjhyJdCc6SVPC9MtAizg7GLxefY7xBCk9a--s0TLhmwe2348ZCk8eJ__4Nyrnl_vEBrP1zxsaHH94cxeHGgdgKxRuAmoJ5N2KZkiWXVhZKOieh0i-Y4kUJpYkz3gglwC28VW6kXJbmXFkoijwyTOC562Qzg6wPheDm68PJ2flwppF1Y3-TXIkYQIr8rV959mKGjZB-MUWyWd7OEkWK5J9T5Xo1nf4dELeJcXyL3AyIlr7qTPA2WfPVHbJ1Gs7s7xKDQBebqejbc1h22tTU0Kpjn9NPvjGxCYNRaF1Sgyrt2LnI0KFz71AC6cDUIvO73UP-2r6x8xXu9S3vkYtrUfN9slHVld8m1LiMQVwprUogz3pbZFCguUQ5CC2lK5KIiF6H2oap53j5xlz39LaZ7nWvUfc6ERp0H5G9QW7Rzf24UiLrl0j3Xa0QhzWkpisl1SAZcE-HZ_5LdhesAf4avo5ysDzAZ6AhRCGAJVlEdno70SE6LfUvX4rI0-FjiCt4WGQqX6_wOxzUj0zdiDzo7GtQBAN3TmSuHv774U_IFriofn88OXlEbuCP7liQO2Sj-bLyu4DmmuJxcBNKPl63Z_4EgGJYLg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Applying+GRADE+to+a+network+meta-analysis+of+antidepressants+led+to+more+conservative+conclusions&rft.jtitle=Journal+of+clinical+epidemiology&rft.au=Bonner%2C+Ashley&rft.au=Alexander%2C+Paul+E.&rft.au=Brignardello-Petersen%2C+Romina&rft.au=Furukawa%2C+Toshi+A.&rft.date=2018-10-01&rft.pub=Elsevier+Inc&rft.issn=0895-4356&rft.volume=102&rft.spage=87&rft.epage=98&rft_id=info:doi/10.1016%2Fj.jclinepi.2018.05.009&rft.externalDocID=S0895435617310855 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0895-4356&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0895-4356&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0895-4356&client=summon |